Question 1

What is Aquestive Therapeutics, Inc.'s total cost of revenue?

Accepted Answer

Aquestive Therapeutics, Inc. (AQST) reported total cost of revenue of $4.02M in Q2 2026.

Question 2

How has Aquestive Therapeutics, Inc.'s total cost of revenue changed year-over-year?

Accepted Answer

Aquestive Therapeutics, Inc.'s total cost of revenue decreased by 11.9% year-over-year, from $4.56M to $4.02M.

Question 3

What is the long-term trend for Aquestive Therapeutics, Inc.'s total cost of revenue?

Accepted Answer

Over 3 years (2022 to 2025), Aquestive Therapeutics, Inc.'s total cost of revenue has grown at a -1.4% compound annual growth rate (CAGR), from $19.39M to $18.56M.

Question 4

What does total cost of revenue mean?

Accepted Answer

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Line item	Three Months Ended June 30, 2026	Three Months Ended June 30, 2025	Six Months Ended June 30, 2026	Six Months Ended June 30, 2025
Revenues	$13,819	$10,003	$28,265	$18,723
Costs and expenses:
Manufacture and supply	4,017	4,561	7,486	8,213
Research and development	3,962	4,105	8,166	9,466
Selling, general and administrative	14,063	12,705	25,040	31,777
Total costs and expenses	22,042	21,371	40,692	49,456
Loss from operations	(8,223)	(11,368)	(12,427)	(30,733)
Other income/(expenses):

Total Cost of Revenue at other companies

Segments

By segment

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Aquestive Therapeutics, Inc.'s total cost of revenue.

Aquestive Therapeutics, Inc. AQST Total Cost of Revenue